Analytical Data
-
基因名
Stfa2
- Application
-
别名
Stfa2;Stf-2;Stf2;Stefin-2
-
种属
Mouse
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P35174
-
表达区间
1-103aa
-
氨基酸序列
MTEYTRKIKGGLSEARPATSEIQEIADKVRPLLEEKTNEKYEKFKAIEYKVQVVQGLNYFIKMNVGRGCYLHINVLSGISSENDLELTGYQTNKAKNDELTYF
-
分子量
17.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Stfa2 is a recombinant protein that has garnered significant attention in the field of biotechnology and molecular biology due to its potential applications in various biotherapeutic processes. Initially identified as a part of the antifungal defense system in certain organisms, Stfa2 has shown promise in its ability to inhibit the growth of pathogenic fungi, making it a key candidate for developing novel antifungal agents. Researchers have focused on elucidating its structure and function, aiming to understand the molecular mechanisms underlying its antifungal activity. The recombinant expression of Stfa2 in suitable host systems allows for functional studies and the exploration of its interactions with fungal cells. This research is crucial as fungal infections pose a serious health threat, particularly for immunocompromised individuals. By harnessing the properties of Stfa2, scientists hope to contribute to the development of more effective treatments for fungal infections, addressing a pressing need in the field of medicine. Additionally, understanding the pathways by which Stfa2 exerts its effects can pave the way for innovative strategies in pathogen control and provide insights into protein engineering for therapeutic uses. The ongoing investigation into Stfa2 is not only expanding our knowledge of antifungal proteins but is also offering avenues for biotechnological advancements in the treatment of fungal diseases.












